RY
Therapeutic Areas
Biolinq Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Biolinq Shine™ Autonomous Time-in-Range Microsensor | Glycemic control management in non-insulin using adults (22+) | Approved |
| Multi-Analyte Platform Development | Metabolic health / multiple biomarkers (Investigational) | Pre-clinical |